Atlas Trials

Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

Clinical trial NCT01869166 · UNKNOWN

Trial details

NCT number
NCT01869166
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced EGFR-positive Solid Tumors
Start date
2013-05-01
Primary completion
2016-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.